±¹³»µµ¼
Àü°øµµ¼/´ëÇб³Àç
ÀǾàÇа£È£°è¿
2013³â 9¿ù 9ÀÏ ÀÌÈÄ ´©Àû¼öÄ¡ÀÔ´Ï´Ù.
Á¤°¡ |
45,000¿ø |
---|
40,500¿ø (10%ÇÒÀÎ)
450P (1%Àû¸³)
ÇÒÀÎÇýÅÃ | |
---|---|
Àû¸³ÇýÅà |
|
|
|
Ãß°¡ÇýÅÃ |
|
À̺¥Æ®/±âȹÀü
¿¬°üµµ¼
»óÇ°±Ç
ÀÌ»óÇ°ÀÇ ºÐ·ù
Ã¥¼Ò°³
¡ºSMART(½º¸¶Æ®) ³»°ú vol.1: ¹ÙÀÌÅ», °¨¿°, Á¾¾ç, ·ù¸¶Æ¼½º¡»´Â ¡´½ÉÆó¼Ò»ý¼úÀ» ½ÃÇàÇÏÀÚ¡µ, ¡´Ç÷¾ÐÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ÃâÇ÷, ¼îÅ© ¹× ¼ö¾×¼Ò»ý¼ú¡µ, ¡´È£ÈíÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ±âµµ ¹× ȯ±â°ü¸®¡µ, ¡´¸Æ¹ÚÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ½É¹Ú¼ö/½ÉÀ帮µëÀå¾Ö¡µµîÀ» ¼ö·ÏÇÏ°í Àִ åÀÌ´Ù.
ÃâÆÇ»ç ¼Æò
Ã¥À» º¸½Ã±â Àü¿¡
¡Ü BCU(Barunlab Contents Universe)¿¡ ´ëÇؼ ¼Ò°³ÇÕ´Ï´Ù.
¾È³çÇϼ¼¿ä. º» Ã¥ÀÇ ÀúÀÚÀÌÀÚ ¹Ù¸¥ÀÇÇבּ¸¼Ò¸¦ ÅëÇØ ²ÞÀ» ½ÇÇöÇسª°¡°í ÀÖ´Â ÀÌ»óºÀÀÔ´Ï´Ù.
Àú´Â ÀÇÇÐÄÜÅÙÃ÷¿¡ °üÇÑ ÀüüÀûÀÎ ·Îµå¸ÊÀ» ¼³°èÇÏ°í ÀÏÂ÷Áø·á¿¡ °ü·ÃµÈ ´ëºÎºÐÀÇ À̽´¸¦ ÃÑ ¸Á¶óÇÏ´Â ÄÜÅÙÃ÷¸¦ Á¦°øÇÏ°íÀÚ Èû¾²°í ÀÖ½À´Ï´Ù.
ÃÖ±Ù ÀÌ·± öÇРȤÀº ¼¼°è°üÀ» BCU(Barunlab Contents Universe)¶ó´Â À̸§¿¡ ´ã¾Æ³»°Ô µÇ¾ú½À´Ï´Ù.
- Objective : Primary care total package
¹Ù¸¥ÀÇÇבּ¸¼Ò´Â ÀÏÂ÷Áø·á¿¡ ´ëÇÑ total solution Á¦½Ã¸¦ ¸ñÇ¥·Î ÇÕ´Ï´Ù.
ÀÇ´ë»ýºÎÅÍ ¼ö·ÃÀÇ(ÀÎÅÏ, ·¹Áö´øÆ®), °øº¸ÀÇ/±ºÀÇ°ü, °³¿øÀÇ/ºÀÁ÷ÀDZîÁö °¢ ½Ã±â, »óȲº°·Î ÀÇ»ç·Î¼ÀÇ ±âº» ÀÚÁúÀ» °®Ã߸ç Áø·á performance¸¦ Á¦´ë·Î ¹ßÈÖÇϱâ À§ÇØ ÇÊ¿äÇÑ ÄÜÅÙÃ÷¸¦ ü°èÀûÀ¸·Î Á¦°øÇÏ°íÀÚ BCU(Barunlab Contents Universe)¶ó´Â ·Îµå¸ÊÀ» ¼³°èÇÏ¿´½À´Ï´Ù.
Total soulution Á¦½Ã¸¦ À§ÇØ °¢ stageº°·Î ÀûÇÕÇÑ, °¢ stage³¢¸® ¿¬°áµÇ´Â Áï, ¿¬¼ÓÀûÀ¸·Î ¿¬°üµÇ´Â ÄÜÅÙÃ÷¸¦ ü°èÀûÀ¸·Î Á¦°øÇϱâ À§ÇÑ ÀüüÀûÀÎ ÀÇÇÐ ÄÜÅÙÃ÷ ·Îµå¸ÊÀÔ´Ï´Ù.
- Strategy
Strategy I
Backbone plus supplement Strategy :
Áß½ÉÃà(»À´ë) + Supplement Àü·«
Áß½ÉÃà(»À´ë): ÀÏÂ÷Áø·á¿¡ °üÇÑ ±âº»ÀûÀÌ°í ÀüüÀûÀÎ »À´ë ±¸Ãà
+
Supplement: Ãß°¡ÀûÀ¸·Î ÇÊ¿äÇÑ ¼¼ºÎÀûÀÎ ºÎºÐ º¸Ãæ
Æ÷°ýÀûÀ¸·Î ´Ù·é´Ù°í Çصµ ÇÑ ±ÇÀÇ Ã¥¿¡ ¸ðµç ºÎºÐÀ» ¿Ïº®ÇÏ°Ô ´ã¾Æ³¾ ¼ö ¾ø±â¿¡ "Áß½ÉÃà + Supplement" Àü·«À» ÅëÇØ ÃÖ´ëÇÑ ÀÏÂ÷Áø·áÀÇ ÁÖ¿ä ¿µ¿ªÀ» ü°èÀûÀ¸·Î ´Ù·ç°íÀÚ ÇÕ´Ï´Ù.
BCU´Â ÀÏÂ÷Áø·á¿¡ ´ëÇÑ total solution Á¦½Ã¸¦ À§ÇØ ½º¸¶Æ® ÀÏÂ÷Áø·á¸Å´º¾ó(±Ù°ÅÆí, ½ÇÀüÆí)À» Áß½ÉÃàÀ¸·Î, ¿©·¯ °ü·Ã º¸Ãæ ÄÜÅÙÃ÷¿ÍÀÇ ¿¬°è¿¡ ÃÊÁ¡À» µÎ¾ú½À´Ï´Ù.
Strategy II
Basic to Bedside Strategy or Principle to Practice
±âÃÊÀÇÇп¡¼ ½ÀµæÇÑ ³»¿ëÀ» ÀÓ»ó¿¡ ÀûÀýÇÏ°Ô Á¢¸ñÇÏ°í È°¿ëÇÒ ¼ö ÀÖµµ·Ï
±âÃʺÎÅÍ ÀÓ»ó±îÁöÀÇ ¿¬¼Ó¼ºÀ» ¿°µÎ¿¡ µÎ¾ú½À´Ï´Ù.
Strategy III
Primary care to Specialized care
¿ì¼± ÀÏÂ÷Áø·á¸¦ ¸¶½ºÅÍÇÏ´Â µ¥ ÁÖ¾ÈÁ¡À» ÁÖ¾ú½À´Ï´Ù.
ÇÑ¹ß ´õ ³ª¾Æ°¡ ÀÏÂ÷Áø·á¸¦ µÑ·¯½Ñ
Àü¹®Áø·áÀÇ ¿µ¿ª±îÁö Á¡Â÷ È®ÀåÇسª°¥ ¿¹Á¤ÀÔ´Ï´Ù.
¡Ü °¨º°Áø´ÜÀÇ Á¤¼®
o ½º¸¶Æ® ³»°ú´Â Strategy III: Primary care to Specialized care¿¡¼ Specialized care¿¡ ÇØ´çÇϴ åÀÔ´Ï ´Ù. ³»°ú¿¡ ÁßÁ¡À» µÎ°í ÀÏÂ÷Áø·á»Ó ¾Æ´Ï¶ó 3Â÷º´¿ø ¿Ü·¡Áø·á, ÀÔ¿øÁø·á¿Í ¿¬°üµÈ Àü¹®Áø·á¿µ¿ª±îÁö ¸Á¶ó ÇÑ Ã¥ÀÔ´Ï´Ù.
o º» ±³Àç´Â Qbook, ½º¸¶Æ® ³»°úÁø·á¸Å´º¾ó(2021³â ÇϹݱâ Ãâ°£¿¹Á¤)°ú Æ®·ÎÀÌÄ«¸¦ ÀÌ·ç´Â Ã¥À̱⵵ ÇÕ´Ï´Ù.
1. ½º¸¶Æ® ³»°ú: º¸´Ù ±âº»ÀûÀÎ ³»¿ë¿¡ ÃÊÁ¡À» ¸ÂÃá Ã¥
2. ½º¸¶Æ® ³»°úÁø·á¸Å´º¾ó: º¸´Ù ½ÇÀüÀûÀÎ ³»¿ë¿¡ ÃÊÁ¡À» ¸ÂÃá Ã¥
3. Q book: Áõ·Ê Áß½ÉÀ¸·Î ÀÌ·ÐÀ» ½ÇÀü¿¡ Á¢¸ñ½ÃÄÑ Áִ å
ÃÊÆÇÀÌ ºÎÁ·ÇÑ ºÎºÐÀ» Å©°Ô °³¼±Çß½À´Ï´Ù. ³»°úÁø·á ¹× ÀÏÂ÷Áø·áÀÇ ±âº»±â¸¦ ´ÙÁö´Â µ¥ À¯¿ëÇÑ Ã¥ÀÌ µÇ±æ ±â´ëÇÕ´Ï´Ù.
¸ñÂ÷
PART 1. ¹ÙÀÌÅ»
SECTION 1. Cardiac arrest ¡æ ½ÉÆó¼Ò»ý¼úÀ» ½ÃÇàÇÏÀÚ!! -------- 2
1. ½ÉÆó¼Ò»ý¼ú: °³¿ä -------- 3
2. ¼ºÀÎ Àü¹® ½ÉÆó¼Ò»ý¼ú(Advanced Cardiovascular Life Support, ACLS) -------- 15
SECTION 2. Ç÷¾ÐÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ÃâÇ÷, ¼îÅ© ¹× ¼ö¾×¼Ò»ý¼ú -------- 32
1. ¼îÅ©: °³¿ä/Ä¡·á ¿øÄ¢ -------- 33
2. ÀúÇ÷·® ¼îÅ©/ÃâÇ÷¼º ¼îÅ©(Hypovolemic shock/Hemorrhagic shock) -------- 43
3. ÆÐÇ÷ ¼îÅ©(Septic shock) -------- 49
4. ½ÉÀ强 ¼îÅ©(Cardiogenic shock) -------- 58
5. ½Å°æ¼º ¼îÅ©(Neurogenic shock) -------- 63
6. ¼ö¾×¿ä¹ý(Fluid therapy) -------- 66
7. ¼öÇ÷¿ä¹ý(Transfusion) -------- 71
SECTION 3. È£ÈíÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ±âµµ ¹× ȯ±â°ü¸® -------- 83
1. È£Èí°ï¶õ¿¡ ´ëÇÑ Á¢±Ù -------- 84
2. »ê¼Ò¿ä¹ý -------- 94
3. ±âµµ ȯ±â/°ü¸® -------- 103
o ºñħ½ÀÀû ±âµµ ȯ±â/°ü¸® -------- 104
o ħ½ÀÀû ±âµµ ȯ±â/°ü¸®: ±â°ü »ð°ü -------- 112
SECTION 4. ¸Æ¹ÚÀÌ ºÒ¾ÈÁ¤ÇÑ °æ¿ì: ½É¹Ú¼ö/½ÉÀ帮µëÀå¾Ö -------- 122
1. ¼¸Æ¿¡ ´ëÇÑ Á¢±Ù -------- 123
2. ºó¸Æ¿¡ ´ëÇÑ Á¢±Ù -------- 126
SECTION 5. ü¿ÂÀÌ»ó¿¡ ´ëÇÑ Á¢±Ù -------- 130
1. ¹ß¿(Fever) -------- 131
o ¹ß¿¿¡ ´ëÇÑ Á¢±Ù -------- 132
o ºÒ¸í¿(Fever of unknown origin) -------- 139
2. Àúü¿Â(Hypothermia) -------- 148
PART 2. °¨¿°
SECTION 1. °¨¿°Áúȯ ±âº» -------- 158
1. ÁÖ¿ä º´¿øü¿¡ ´ëÇÑ ÀÌÇØ -------- 159
2. Ç×»ýÁ¦¿¡ ´ëÇÑ ÀÌÇØ -------- 161
3. ÀÇ·á °ü·Ã °¨¿° -------- 176
o Ä«Å×ÅÍ °ü·Ã °¨¿°(Ä«Å×ÅÍ °ü·Ã ±ÕÇ÷Áõ) -------- 178
o Clostridium difficile Infection [CDI, °ÅÁþ¸·´ëÀå¿°(Pseudomembranous colitis, PMC)] -------- 182
SECTION 2. °¨¿°°ü¸®/¿¹¹æ -------- 185
1. º´¿øüÀÇ Ä§ÀÔÀ» ¸·ÀÚ! -------- 186
2. ÀüÆÄ °úÁ¤À» Â÷´ÜÇÏÀÚ! -------- 195
o Ç¥ÁØÁÖÀÇ(Standard precautions) -------- 196
o ÀüÆÄ°æ·Îº° °Ý¸® ------- 202
3. ¸é¿ª·ÂÀ¸·Î ´ëºñÇÏÀÚ! ¿¹¹æÁ¢Á¾ -------- 206
o ¿¹¹æÁ¢Á¾¿¡ ´ëÇÑ ÀÌÇØ -------- 207
o ¿¹¹æÁ¢Á¾ÀÇ ¿øÄ¢ -------- 210
o ¿¹¹æÁ¢Á¾ ÀÏÁ¤ »ìÆ캸±â! -------- 221
SECTION 3. º´¿øüº°: ¼¼±Õ °¨¿° -------- 227
1. ±×¶÷¾ç¼º±Õ °¨¿° -------- 228
o Æ÷µµ¾Ë±Õ(Staphylococcus) °¨¿° -------- 229
o »ç½½¾Ë±Õ(Streptococcus) °¨¿° -------- 233
o Æó·Å¾Ë±Õ(Pneumococcus) °¨¿° -------- 237
o Àå¾Ë±Õ(Enterococcus) °¨¿° -------- 241
o Corynebacterium °¨¿°: µðÇÁÅ׸®¾Æ(Diphtheria) µî -------- 245
o ¸®½ºÅ׸®¾Æ(Listeria) °¨¿° -------- 249
2. ±×¶÷À½¼º±Õ °¨¿° -------- 252
o Neisseria °¨¿°: ¼ö¸·¾Ë±Õ(Meningococcus) °¨¿° -------- 254
o Neisseria °¨¿°: ÀÓ±Õ(Gonoccocus) °¨¿° -------- 258
o Çì¸ðÇʷ罺/¸ð¶ô¼¿¶ó(Hemophilus/Moraxella) °¨¿° -------- 262
o ³ì³ó±Õ/¿¡½Ã³×Åä¹ÚÅÍ(Pseudomonas/Acinetobacter) °¨¿° -------- 267
o »ì¸ð³Ú¶ó(ÀåƼǪ½º)/½Ã°Ö¶ó(Salmonella/Shigella) °¨¿° -------- 273
o ºñºê¸®¿À(Vibrio) °¨¿°: ÄÝ·¹¶ó/±âŸ ºñºê¸®¿À -------- 280
o ±×¶÷À½¼º Àå³»¼¼±Õ(Gram negative enteric bacteria) °¨¿° -------- 286
o ¹éÀÏÇØ/±âŸ º¸µ¥ÅÚ¶ó °¨¿° -------- 294
o Ä·ÇʷιÚÅÍ/Ç︮ÄÚ¹ÚÅÍ °¨¿° -------- 300
o ·¹Áö¿À³Ú¶ó °¨¿° -------- 304
3. ±âŸ ¼¼±Õ °¨¿° -------- 307
o ¸¶ÀÌÄÚÇöóÁ/Ŭ¶ó¹Ìµð¾Æ °¨¿° -------- 308
o ³ª¼±±Õ(Spirochetes) °¨¿° -------- 316
o ¹Ì»ê¼Ò¼º/¹«»ê¼Ò¼º ¼¼±Õ °¨¿° -------- 321
o ¸®ÄÉÂ÷ °¨¿°: ÂêÂê°¡¹«½Ãº´, Å¥¿ µî -------- 329
4. ¹ÌÄÚ¹ÚÅ׸®¾Æ(°áÇÙ±Õ) °¨¿° ------- 333
o °áÇÙÀÇ Áø´Ü ¹× Ä¡·á -------- 334
o Àẹ°áÇÙ °¨¿° -------- 349
o ºñ°áÇÙ Ç×»ê±Õ(Non-Tuberculous Mycobacterium, NTM) °¨¿° -------- 355
SECTION 4. ¹ÙÀÌ·¯½º °¨¿° -------- 363
1. »ç¶÷Ç츣Æ佺 ¹ÙÀÌ·¯½º(Herpesviridae) °¨¿° -------- 364
o ´Ü¼øÆ÷Áø ¹ÙÀÌ·¯½º(Herpes simplex virus) °¨¿° -------- 365
o ¼öµÎ-´ë»óÆ÷Áø ¹ÙÀÌ·¯½º(Varicella-Zoster virus) °¨¿° -------- 368
o ¿¦½ºÅ¸Àι٠¹ÙÀÌ·¯½º(Epstein Barr virus) °¨¿° -------- 379
o °Å´ë¼¼Æ÷ ¹ÙÀÌ·¯½º(Cytomegalovirus) °¨¿° -------- 382
2. »ç¶÷À¯µÎÁ¾ ¹ÙÀÌ·¯½º(Human papillomaviruses, HPVs) °¨¿° -------- 386
3. ÀÎÇ÷翣ÀÚ(Influenza) °¨¿° -------- 389
4. Àå ¹ÙÀÌ·¯½º(¿£Å×·Î ¹ÙÀÌ·¯½º, Enterovirus) °¨¿° -------- 397
5. Äڷγª ¹ÙÀÌ·¯½º(Coronavirus) °¨¿° -------- 404
o Äڷγª ¹ÙÀÌ·¯½º °¨¿°: Overview -------- 405
o [Special review] Äڷγª 19(COVID-19) °¨¿° -------- 409
6. ÀϺ»³ú¿° ¹ÙÀÌ·¯½º(Japanese encephalitis virus) -------- 418
7.°ø¼öº´(±¤°ßº´, Rabies)) -------- 421
8. HIV °¨¿°/ÈÄõ¸é¿ª°áÇÌÁõÈıº(AIDS) -------- .. 426
9. ÃÖ±Ù À¯ÇàÇÏ°í ÀÖ´Â ¹ÙÀÌ·¯½º °¨¿°/ÇØ¿ÜÀ¯ÀÔ ¹ÙÀÌ·¯½º °¨¿° -------- 435
SECTION 5. Áø±Õ °¨¿° -------- 442
1. ĵð´ÙÁõ(Candidiasis) -------- 443
2. Å©¸³ÅäÄÚÄí½ºÁõ(Cryptococcosis) -------- 448
3. ¾Æ½ºÆ丣±æ·ç½ºÁõ(Aspergillosis) -------- 451
4. ÅаõÆÎÀÌÁõ(Mucormycosis) -------- 456
5. ÆóÆ÷ÀÚÃæÁõ(Pneumocystis jirovecii) -------- 461
6. ±âŸ Áø±Õ °¨¿° -------- 466
SECTION 6. ±â»ýÃæ °¨¿° -------- 475
1. ¿¬Ãæ(Helminths): ¼±Ãæ·ù, ÈíÃæ·ù, Á¶Ãæ·ù -------- 476
2. ¿øÃæ(Protozoa): ¸»¶ó¸®¾Æ µî -------- 486
PART 3. Á¾¾ç
SECTION 1. Á¾¾çÁúȯÀÇ Á¢±Ù -------- 500
[supplement] ¾Ï¿¡ ´ëÇÑ ±âº»ÀûÀÎ ÀÌÇØ -------- 501
1. Á¾¾çÁúȯÀÇ ÀϹÝÀûÀÎ Á¢±ÙÀü·« -------- 504
2. ¾Ï °ËÁø -------- 508
3. Á¾¾ç Ç¥ÁöÀÚ(Tumor marker) -------- 511
SECTION 2. Á¾¾çÁúȯÀÇ Ä¡·á -------- 515
1. ¾Ï Ä¡·á ¿øÄ¢ -------- 516
2. Ä¡·á ¹ÝÀÀÀÇ Æò°¡ -------- 519
3. ¹æ»ç¼± Ä¡·á(Radiotherapy) -------- 525
SECTION 3. Ç×¾ÏÈÇпä¹ý -------- 529
1. Ç×¾ÏÈÇпä¹ýÀÇ ¿øÄ¢ -------- 530
2. ÁÖ¿ä Ç×¾ÏÁ¦ -------- 533
o Conventional agents/È£¸£¸óÄ¡·áÁ¦ -------- 534
o Ç¥ÀûÄ¡·áÁ¦(Target therapy) -------- 541
o ¸é¿ªÄ¡·áÁ¦(Immunotherapy) -------- 543
3. °¡½¿ ÅëÁõ(Chest pain):Musculoskeletal origin -------- 304
SECTION 4. ¾Ï °ü·Ã Áõ»ó ¹× ÇÕº´Áõ °ü¸® -------- 545
1. ¾Ï¼º ÅëÁõ °ü¸® -------- 546
2. ±¸Á¶Àû/Æó¼â¼º ÇÕº´Áõ -------- 557
o »ó´ëÁ¤¸ÆÁõÈıº(Superior vena cava syndrome) -------- 558
o ¾Ç¼º ô¼ö¾Ð¹ÚÁõÈıº(Malignant spinal cord compression) -------- 559
3. Ä¡·á °ü·Ã ÇÕº´Áõ -------- 560
o Á¾¾ç¿ëÇØÁõÈıº(Tumor lysis syndrome) -------- 560
PART 4. ·ù¸¶Æ¼½º
SECTION 1. ¸é¿ª¸Å°³Áúȯ -------- 564
1. Àü½Å È«¹Ý ·çǪ½º(Systemic lupus erythematosus, SLE) -------- 565
2. Àü½Å °æÈÁõ(Systemic sclerosis, SSc) -------- 576
3. ¼î±×·» ÁõÈıº(Sj?gren's syndrome) -------- 587
4. º£Ã¼Æ®º´(Beh?et's disease) -------- 594
5. Ç÷°ü¿°(Vasculitis) -------- 599
6. ôÃß °üÀýº´Áõ(Spondyloarthropathies, SpA): °Á÷ ôÃß¿°(Ankylosing spondylitis, AS)/¹ÝÀÀ °üÀý¿°(Reactive arthritis, ReA) -------- 612
7. ·ù¸¶Æ¼½º °üÀý¿°(Rheumatoid arthritis, RA) -------- 621
SECTION 2. °üÀý°ú ÀÎÁ¢Á¶Á÷ Áúȯ -------- 634
1. °ñ°üÀý¿°(Osteoarthritis, OA) -------- 635
2. °áÁ¤ ¿¬°ü °üÀýº´Áõ: Åëdz(Gout)/°¡¼ºÅëdz(CPPD disease) -------- 648
3. °¨¿° °üÀý¿°(Infectious arthritis) -------- 668
4. ¼¶À¯±ÙÀ°Åë(Fibromyalgia, FM) -------- 673
ÀúÀÚ¼Ò°³
»ý³â¿ùÀÏ | - |
---|
ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.
ÁÖ°£·©Å·
´õº¸±â»óÇ°Á¤º¸Á¦°ø°í½Ã
À̺¥Æ® ±âȹÀü
Àü°øµµ¼/´ëÇб³Àç ºÐ¾ß¿¡¼ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥
ÆǸÅÀÚÁ¤º¸
»óÈ£ |
(ÁÖ)±³º¸¹®°í |
---|---|
´ëÇ¥ÀÚ¸í |
¾Èº´Çö |
»ç¾÷ÀÚµî·Ï¹øÈ£ |
102-81-11670 |
¿¬¶ôó |
1544-1900 |
ÀüÀÚ¿ìÆíÁÖ¼Ò |
callcenter@kyobobook.co.kr |
Åë½ÅÆǸž÷½Å°í¹øÈ£ |
01-0653 |
¿µ¾÷¼ÒÀçÁö |
¼¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù) |
±³È¯/ȯºÒ
¹ÝÇ°/±³È¯ ¹æ¹ý |
¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼ ½Åû °¡´É |
---|---|
¹ÝÇ°/±³È¯°¡´É ±â°£ |
º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É |
¹ÝÇ°/±³È¯ ºñ¿ë |
º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã |
¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯ |
·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì |
»óÇ° Ç°Àý |
°ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½ |
¼ÒºñÀÚ ÇÇÇغ¸»ó |
·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© ó¸®µÊ ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀǼҺñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ |
(ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
(ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.
¹è¼Û¾È³»
±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
Ãâ°í°¡´É ½Ã°£ÀÌ ¼·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.
±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.
¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.